Insight: Big Pharma braces for retirement of favorite regulator

mercredi 9 octobre 2013

Woodcock, Director of the Center for Drug Evaluation and Research at FDA, speaks during the Reuters Health Summit in New York The retirement of Dr. Janet Woodcock as head of the Food and Drug Administration's pharmaceutical division is at least a year away, but already the industry she regulates is worrying about who will replace ...








via Business News - Yahoo Finance http://finance.yahoo.com/news/insight-big-pharma-braces-retirement-050603072.html

0 commentaires:

Enregistrer un commentaire